Aethon, an innovator of healthcare autonomous mobile robots, recently declared that it has secured an investment from Mitsui USA. This investment by Mitsui USA is a part of the latest round of $7.1 M in funding for Aethon.
Aethon will improve its aggressive strategy upon receiving the investment from international trade and investment company, Mitsui USA. In addition, by connecting with global leaders, Aethon can widen its technology platform, thereby progressing into new global markets. As Aethon seeks potential expansion prospects into the markets of Asia, the potential of Mitsui USA to offer resources and dynamic operational perspective will also be enhanced following this investment. Following Aethon’s strategic partnership with the Bosch Group in 2010, the company will pursue its European expansion.
After its introduction into the commercial markets in 2005, Aethon has experienced considerable expansion, especially with its self-guided TUG robots that achieve 50,000 deliveries per week consistently. Aethon’s TUGs have been deployed in hospitals all over the country for precision transportation of medication, equipment, meals, and linens.
The General Manager of Mitsui’s new business development department, Shigeyuki Toya said that Aethon’s dynamic performance, strong business strategy, vast market potential and expertise management team inspired Mitsui USA to come forward to invest. Mitsui USA expects the healthcare robotics segment to grow by improving care, efficiencies, patient safety, and realizing major conservations.
Besides achieving investment funds from Mitsui USA and the Bosch Group, Aethon has also acquired investments from major venture capital firms like Trident Capital.